Authors

• Naomi Wilcox (ORCID: https://orcid.org/0000-0002-7709-7029)
• Michael Lush (ORCID: https://orcid.org/0000-0001-5945-3440)
• Jonathan P. Tyrer (ORCID: https://orcid.org/0000-0003-3724-4757)
• Lorenzo Ficorella (ORCID: https://orcid.org/0000-0002-0577-1571)
• Joe Dennis (ORCID: https://orcid.org/0000-0003-4591-1214)
• Xin Yang (ORCID: https://orcid.org/0000-0003-1304-7492)
• Carmen Petitjean
• Jacques Simard (ORCID: https://orcid.org/0000-0001-6906-3390)
• Douglas F. Easton
• Antonis C. Antoniou

Institutions

• University of Cambridge (GB)
• British Heart Foundation (GB)
• Cancer Research UK Cambridge Center (GB)
• Centre hospitalier universitaire de Québec (CA)
• Bridge University (SS)
• Centre hospitalier de l'Université Laval (CA)
• Université Laval (CA)

Publication Details

Journal

JNCI Journal of the National Cancer Institute

Published

2024-12-11

DOI

https://doi.org/10.1093/jnci/djae335

Citations

11

Primary Topic

Global Cancer Incidence and Screening

Type

article

Field-Weighted Citation Impact

3.11

Funders

• Genome Canada
• Wellcome Trust
• Scottish Government
• Gray Foundation
• Fondation du cancer du sein du Québec
• Government of Canada
• Cancer Research UK
• National Institute for Health and Care Research
• British Heart Foundation
• Department of Health and Social Care
• European Commission
• Public Health Agency
• Chief Scientist Office, Scottish Government Health and Social Care Directorate
• Canadian Institutes of Health Research
• Medical Research Council
• Engineering and Physical Sciences Research Council
• Economic and Social Research Council
• Health and Social Care Research and Development Division
• NIHR Cambridge Biomedical Research Centre